As systemic inflammation is associated with an increased risk of developing osteoporosis in older subjects, it may be that enhanced IL-1 signaling increases osteoclast activity in the vertebrae only in combination with ageing, probably explaining the lack of structural pathology observed in the vertebrae of Il1rn−/− mice. This evidence concerns the gene IL1B and osteoporosis.